Skip to main content
Canna~Fangled Abstracts

Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome

By August 23, 2024September 23rd, 2024No Comments


doi: 10.1021/acsptsci.4c00002. eCollection 2024 Sep 13.

Affiliations 

Abstract

Brain aging is associated with cognitive decline, reduced synaptic plasticity, and altered metabolism. The activity of mechanistic target of rapamycin (mTOR) has a major impact on aging by regulating cellular metabolism. Although reduced mTOR signaling has a general antiaging effect, it can negatively affect the aging brain by reducing synaptogenesis and thus cognitive functions. Increased mTOR activity facilitates aging and is responsible for the amnestic effect of the cannabinoid receptor 1 agonist Δ9-tetrahydrocannabinol (THC) in higher doses. Long-term low-dose Δ9-THC had an antiaging effect on the brain by restoring cognitive abilities and synapse densities in old mice. Whether changes in mTOR signaling and metabolome are associated with its positive effects on the aging brain is an open question. Here, we show that Δ9-THC treatment has a tissue-dependent and dual effect on mTOR signaling and the metabolome. In the brain, Δ9-THC treatment induced a transient increase in mTOR activity and in the levels of amino acids and metabolites involved in energy production, followed by an increased synthesis of synaptic proteins. Unexpectedly, we found a similar reduction in the mTOR activity in adipose tissue and in the level of amino acids and carbohydrate metabolites in blood plasma as in animals on a low-calorie diet. Thus, long-term Δ9-THC treatment first increases the level of energy and synaptic protein production in the brain, followed by a reduction in mTOR activity and metabolic processes in the periphery. Our study suggests that a dual effect on mTOR activity and the metabolome could be the basis for an effective antiaging and pro-cognitive medication.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

References

    1. Han J. H.; Kim W. Peripheral CB1R as a Modulator of Metabolic Inflammation. FASEB J. 2021, 35 (4), e2123210.1096/fj.202001960R. – DOI – PubMed
    1. Albayram O.; Alferink J.; Pitsch J.; Piyanova A.; Neitzert K.; Poppensieker K.; Mauer D.; Michel K.; Legler A.; Becker A.; Monory K.; Lutz B.; Zimmer A.; Bilkei-Gorzo A. Role of CB1 Cannabinoid Receptors on GABAergic Neurons in Brain Aging. Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (27), 11256–11261. 10.1073/pnas.1016442108. – DOI – PMC – PubMed
    1. Bilkei-Gorzo A.; Albayram O.; Draffehn A.; Michel K.; Piyanova A.; Oppenheimer H.; Dvir-Ginzberg M.; Rácz I.; Ulas T.; Imbeault S.; Bab I.; Schultze J. L.; Zimmer A. A Chronic Low Dose of Δ9-Tetrahydrocannabinol (THC) Restores Cognitive Function in Old Mice. Nat. Med. 2017, 23 (6), 782–787. 10.1038/nm.4311. – DOI – PubMed
    1. Komorowska-Müller J. A.; Gellner A. K.; Ravichandran K. A.; Bilkei-Gorzo A.; Zimmer A.; Stein V. Chronic Low-Dose Δ9-Tetrahydrocannabinol (THC) Treatment Stabilizes Dendritic Spines in 18-Month-Old Mice. Sci. Rep. 2023, 13, 1–8. 10.1038/s41598-022-27146-2. – DOI – PMC – PubMed
    1. O’Donnell C.; Nolan M. F.; van Rossum M. C. W. Dendritic Spine Dynamics Regulate the Long-Term Stability of Synaptic Plasticity. J. Neurosci. 2011, 31 (45), 16142–16156. 10.1523/JNEUROSCI.2520-11.2011. – DOI – PMC – PubMed

LinkOut – more resources


Leave a Reply